Basic and Translational Investigations

   Molecular Genetics

Hao Ding, Luba Roncari, Xiaoli Wu, Nelson Lau, Patrick Shannon, Andras Nagy, and Abhijit Guha

Expression and hypoxic regulation of angiopoietins in human astrocytomas
Neuro-oncol 2001; 3(1): 1-10; DOI:10.1215/15228517-3-1-1 [Abstract] [PDF] [References]  

   Tumor Biology

Anna J. Janss, Amit Maity, Cheng-Bi Tang, Ruth J. Muschel, W. Gillies McKenna, Leslie Sutton, and Peter C. Phillips

Decreased cyclin B1 expression contributes to G₂ delay in human brain tumor cells after treatment with camptothecin
Neuro-oncol 2001; 3(1): 11-21; DOI:10.1215/15228517-3-1-11 [Abstract] [PDF] [References]  

   Preclinical Experimental Therapeutics

Shunichi Yokoyama, Hirofumi Hirano, Naruhito Wakimaru, Krishna Pada Sarker, and Jun-ichi Kuratsu

Inhibitory effect of epigallocatechin-gallate on brain tumor cell lines in vitro
Neuro-oncol 2001; 3(1): 22-28; DOI:10.1215/15228517-3-1-22 [Abstract] [PDF] [References]  

Clinical Investigations

   Clinical Therapy Trials - Other

Harry S. Greenberg, Marc C. Chamberlain, Michael J. Glantz, and Songbai Wang

Adult medulloblastoma: Multiagent chemotherapy
Neuro-oncol 2001; 3(1): 29-34; DOI:10.1215/15228517-3-1-29 [Abstract] [PDF] [References]  

Robert O. Dillman, W. Michael Shea, D. Fritz Tai, Khosrow Mahdavi, Neil M. Barth, Bharati R. Kharkar, Marshall M. Poor, Curtis K. Church, and Carol DePriest

Interferon-2a and 13-cis-retinoic acid with radiation treatment for high-grade glioma
Neuro-oncol 2001; 3(1): 35-41; DOI:10.1215/15228517-3-1-35 [Abstract] [PDF] [References]  

   Medical Neuro-Oncology

Marc C. Chamberlain, Patty A. Kormanik, and Michael J. Glantz

A comparison between ventricular and lumbar cerebrospinal `uid cytology in adult patients with leptomeningeal metastases
Neuro-oncol 2001; 3(1): 42-45; DOI:10.1215/15228517-3-1-42 [Abstract] [PDF] [References]  

Symposium Review

   Clinical Therapy Trials - Outcome

Nancy D. Doolittle, Clarke P. Anderson, W. Archie Bleyer, J. Gregory Cairncross, Timothy Cloughesy, Stephen L. Eck, Paul Guastadisegni, Walter A. Hall, Leslie L. Muldoon, Sunil J. Patel, David Peereboom, Tali Siegal, Edward A. Neuwelt for the Blood-Brain Barrier Disruption Consortium

Importance of dose intensity in neurooncology clinical trials: Summary Report of the Sixth Annual Meeting of the Blood-Brain Barrier Disruption Consortium
Neuro-oncol 2001; 3(1): 46-54; DOI:10.1215/15228517-3-1-46 [Abstract] [PDF] [References]  

Letter to the Editor

Kendra Peterson

Finding the Balance
Neuro-oncol 2001; 3(1): 55-56; DOI:10.1215/15228517-3-1-55 [PDF] [References]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.